Information Provided By: 
Fly News Breaks for March 12, 2018
CI, ESRX
Mar 12, 2018 | 07:50 EDT
As previously reported, Bernstein analyst Lance Wilkes upgraded Express Scripts (ESRX) to Market Perform from Underperform, stating that while he continues to be bearish on the underlying business, he views the deal to be acquired by Cigna (CI) for approximately $91 per share as a "very positive outcome." He would expect regulatory approval based upon lack of overlap, though Wilkes thinks it will likely be an extended regulatory process.
News For ESRX;CI From the Last 2 Days
There are no results for your query ESRX;CI
